{"name":"Nuwellis, Inc.","slug":"nuwellis-inc","ticker":"","exchange":"","domain":"","description":"Nuwellis, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative treatments for fluid overload in patients with heart failure and other conditions. The company's lead product, IV Loop Diuretics, is currently marketed, while it continues to explore other diuretic options in earlier stages of development.","hq":"","founded":0,"employees":"~50","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":8270000,"revenueGrowth":-5.4,"grossMargin":62,"rdSpend":2712000,"netIncome":-17521000,"cash":1085000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"IV Loop Diuretics","genericName":"IV Loop Diuretics","slug":"iv-loop-diuretics","indication":"Acute decompensated heart failure with fluid overload","status":"marketed"}]}],"pipeline":[{"name":"IV Loop Diuretics","genericName":"IV Loop Diuretics","slug":"iv-loop-diuretics","phase":"marketed","mechanism":"IV loop diuretics inhibit the sodium-potassium-chloride co-transporter in the thick ascending limb of the loop of Henle, increasing urinary sodium and water excretion.","indications":["Acute decompensated heart failure with fluid overload","Edema associated with congestive heart failure, renal disease, or hepatic cirrhosis","Hypertension","Pulmonary edema"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE8xT25ya0dLV3F0MDJzdWNLdThsUFBBRzl6Nlllb29UbHZmd2dfblB6TVpFMXd3RnRVMEVlaC1sOUVRejhhSkdXSFpndm4zOHlCblE?oc=5","date":"2026-04-07","type":"pipeline","source":"Yahoo Finance UK","summary":"Nuwellis, Inc. (NUWE) stock price, news, quote and history - Yahoo Finance UK","headline":"Nuwellis, Inc. (NUWE) stock price, news, quote and history","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNMGM1ZWtJb1VOQWRBSTZidXU1SUwtMHpfWFJwQmc3LTdWbFF6cGJHQ2RjczRfNWxmMXpFT3YtUlI0NmJ0THlQM2dxNVJ4cnFkMEJTUEROUldWVWlUMlBJOFFsZTlseFpDZ2hzcGo2blRlZmMtOEx4anZhNHd1dDg5ZUVVeGZYR1B6Mm5udHJHYVNhaEpSVG9rY2dwTmRlMUZMSEllZnRBSEhDVVplNUV5aXZ4Y193TWRkUDUydjZ5ZFE?oc=5","date":"2026-03-18","type":"pipeline","source":"Stock Titan","summary":"Nuwellis (NASDAQ: NUWE) director Emerson Martin J submits initial Form 3 - Stock Titan","headline":"Nuwellis (NASDAQ: NUWE) director Emerson Martin J submits initial Form 3","sentiment":"neutral"},{"date":"2026-03-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOSVAtRDJXUFo1eTRnNlhhdHBRRmVPTUcteXVRZktwenhCR1dia0ZhNGdpZlk3X2tpZmQxUU5tUHlIZlVJZ2o4and1SEF0OGhYbGJBTl95WEo0OUR0bW5hVkdjM1pDWFd6bWZTTFV5UjNvZVRDRHBkMEhmOGlzdWYtRDc0ZjRqNUxOcURLRWdqaWpwRmp0ZUpXdm8xLWdfbDRJNjBvMHM0SjNYUXp0cTR0dmRySnJGTUxZT2xF?oc=5","date":"2026-03-11","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Wednesday's After-Market Session - Acurx Pharmaceuticals (NASDAQ:ACXP), A - Benzinga","headline":"12 Health Care Stocks Moving In Wednesday's After-Market Session - Acurx Pharmaceuticals (NASDAQ:ACXP), A","sentiment":"neutral"},{"date":"2026-03-11","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQNTZ5NG9pX2JiaHpZMGY0TmJ3U0h6YjNoc3I1bDFkdVc2dmVYNHVoTmhKU1N3Tl9xajZ4OEdadURWZTF0eWl2dDVaZmpRano5Sk5wdG9MdW4tT3d3eWI5WVIyd1NKdmV1STRuLVN2aTNMOWtwMEVpY3hBZVllUm5ETFlMNlpJSS1KeVBHVXdIang4V1pudnZ0NnlEODNNNkZaTnZLNW8yQVZoRkVPZ3o0RWJMaEVxdjcxWGNLYTJqZ0F5SHFtUTFsbUY0RXFXV0F1dkRMTw?oc=5","date":"2026-01-27","type":"pipeline","source":"Benzinga","summary":"NUWE Stock: How This $2 Microcap Secured An Infant Healthcare Monopoly - Nuwellis (NASDAQ:NUWE) - Benzinga","headline":"NUWE Stock: How This $2 Microcap Secured An Infant Healthcare Monopoly - Nuwellis (NASDAQ:NUWE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPY1dfWEQwSm5Ta2JtUFJYV2RRX1liczViTU4yaGI0aDh2TkxrQVBpa3ZycmNWM3F5bjhnSDltXzc1WmVuQjlaa2drNElNZmNXTGdvSVctZldudkpSaFVJWHNueHlmTkhyY0REc2hBc2Vwc2hzRTMxVmxsM0dyM3B4eHlTQ3FGQzg0Z2lNbk03clRCRlpqZ04ydGUyRHR2VGNHZE5JZWdHdV92QXlndFJtbDlNb19FN294bVFmWEEwdDJOOXNWSGdLX3l5UzRaN2RMRmxZNUVBQlJmUkJp?oc=5","date":"2026-01-27","type":"regulatory","source":"Benzinga","summary":"Why Biomx Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket - Benzinga","headline":"Why Biomx Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxQSHdUUTBFNHhZNjktdGVGMnd5MXVEVVdQNXpqQXJlY1dsOE1nX1NsLVcxQVpsQnIzWFJJS2JJSWUwY1dHbzZLNElTbG1ST3MyMHdSZXpBbTl3ZkxqZUNhbm5CVUR6YzJ3Mi1xVDBfb21NUmZPdVdxN0d5TFZ1emJaOFZhUllORjJ5NUc2NGhSeTlha2R4dGdYYmxBNGV3TFBMZnp2dkNyLUZsbnNmUHdodlZBLTFTbms4THZwYnRvZUtvc3MxdzJaMHFNS0EzRlVfU3BJMl9nOVlmMTNKRGhTbmEzUGZRcXhiaVNINlBJdEJwR0xObUhPM2xVeFNDcnp3QVR6VFJoMG4xd1k?oc=5","date":"2026-01-23","type":"pipeline","source":"Quiver Quantitative","summary":"Nuwellis, Inc. Appoints Katharyn Field and Mika Grasso to Board of Directors; Dave McDonald, Mike McCormick, and Dr. Maria Costanzo Resign - Quiver Quantitative","headline":"Nuwellis, Inc. Appoints Katharyn Field and Mika Grasso to Board of Directors; Dave McDonald, Mike McCormick, and Dr. Mar","sentiment":"neutral"},{"date":"2026-01-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-05","type":"pipeline","source":"Mint","summary":"Wall Street Today: Dow, Nasdaq, S&P 500 open higher as investors focus on optimism over potential US Fed rate cut - Mint","headline":"Wall Street Today: Dow, Nasdaq, S&P 500 open higher as investors focus on optimism over potential US Fed rate cut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5kMHhOR1VrTzQxakczME1seWlWcFZUV0Nqbm01Y0Mzei1uZTJCNzVHckdRMjFnRWdxMGdvbGZad2RSdWhlYTdna2NzMkQ0V21x?oc=5","date":"2024-02-12","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":8270000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":8270000,"period":"2025-12-31"},{"value":8740000,"period":"2024-12-31"},{"value":8864000,"period":"2023-12-31"},{"value":8543000,"period":"2022-12-31"},{"value":7921000,"period":"2021-12-31"},{"value":7441000,"period":"2020-12-31"}],"grossProfit":5124000,"grossProfitHistory":[],"rdSpend":2712000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-17521000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":1085000,"cashHistory":[],"totalAssets":6118000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}